/Equities/AIMX/COIL/RNS

Secondary share class. The ordinary shares trade as ROQ (Roquefort Therapeutics PLC). Director, financial and RNS data shown here are for the issuer.

Coiled Therapeutics PLC RNS

/Equities/AIMX/COIL/RNS

Secondary share class. The ordinary shares trade as ROQ (Roquefort Therapeutics PLC). Director, financial and RNS data shown here are for the issuer.

Coiled Therapeutics PLC RNS

/Equities/AIMX/COIL/RNS

Secondary share class. The ordinary shares trade as ROQ (Roquefort Therapeutics PLC). Director, financial and RNS data shown here are for the issuer.

/Equities/AIMX/COIL/RNS

Secondary share class. The ordinary shares trade as ROQ (Roquefort Therapeutics PLC). Director, financial and RNS data shown here are for the issuer.

Coiled Therapeutics PLC RNS

Date	Time	Date	TitleTitle (filtered)
07/07/26	07:00:04	7 Jul 2026	Coiled Advances Next-Generation AO-252 Formulation	Coiled Advances Next-Generation AO-252 Formulation
24/06/26	12:30:00	24 Jun 2026	Company Presentation	Company Presentation
24/06/26	11:18:46	24 Jun 2026	Result of AGM	Result of AGM
24/06/26	07:00:03	24 Jun 2026	Appointment of Independent Non-Executive Director	Appointment of Independent Non-Executive Director
19/06/26	07:00:06	19 Jun 2026	Life Sciences Investor Forum	Life Sciences Investor Forum
18/06/26	07:00:07	18 Jun 2026	Proactive One2One Investor Forum	Proactive One2One Investor Forum
17/06/26	09:37:54	17 Jun 2026	Grant of Share Options	Grant of Share Options
17/06/26	07:00:06	17 Jun 2026	Establishment of Medical Advisory Board	Establishment of Medical Advisory Board
08/06/26	07:00:12	8 Jun 2026	Appointment of Ozgur Sahin as Scientific Advisor	Appointment of Ozgur Sahin as Scientific Advisor
29/05/26	07:00:02	29 May 2026	Issue of Equity	Issue of Equity
27/05/26	07:00:06	27 May 2026	Notice of Annual General Meeting	Notice of Annual General Meeting
19/05/26	07:00:08	19 May 2026	Commencement of Trading on US OTCQB Venture Market	Commencement of Trading on US OTCQB Venture Market
07/05/26	07:01:01	7 May 2026	Attendance at Endless Frontier Labs 2026	Attendance at Endless Frontier Labs 2026
07/05/26	07:00:07	7 May 2026	Appointment of Non-Executive Director	Appointment of Non-Executive Director
06/05/26	07:00:05	6 May 2026	Annual Report & Financial Statements	Annual Report & Financial Statements
15/04/26	07:00:09	15 Apr 2026	Presentation at 18th Annual World Cancer Congress	Presentation at 18th Annual World Cancer Congress
08/04/26	07:00:07	8 Apr 2026	Clinical Trial Update	Clinical Trial Update
01/04/26	07:00:04	1 Apr 2026	Total Voting Rights	Total Voting Rights
27/03/26	08:00:00	27 Mar 2026	Readmission - Roquefort Therapeutics Plc	Readmission - Roquefort Therapeutics Plc
27/03/26	07:00:09	27 Mar 2026	Admission to Trading and First Day of Dealings	Admission to Trading and First Day of Dealings
26/03/26	13:00:01	26 Mar 2026	Investor Presentation	Investor Presentation
26/03/26	12:08:49	26 Mar 2026	Result of General Meeting	Result of General Meeting
25/03/26	07:00:09	25 Mar 2026	Lyramid SPA & MK Cell License Update	Lyramid SPA & MK Cell License Update
02/03/26	08:00:00	2 Mar 2026	Schedule One - Roquefort Therapeutics PLC	Schedule One - Roquefort Therapeutics PLC
02/03/26	07:00:11	2 Mar 2026	Proposed Acquisition and Fundraise of £8.5 million	Proposed Acquisition and Fundraise of £8.5 million
25/02/26	07:00:10	25 Feb 2026	Transaction Update & Notice of Intention to Delist	Transaction Update & Notice of Intention to Delist
15/01/26	07:00:10	15 Jan 2026	Research Note Published	Research Note Published
12/12/25	07:00:06	12 Dec 2025	Clinical Trial & License Agreement Update	Clinical Trial & License Agreement Update
09/12/25	07:00:04	9 Dec 2025	Conversion of CLNs	Conversion of CLNs
01/12/25	10:35:41	1 Dec 2025	Ex-Entitlement Date - Unlisted RNV Shares	Ex-Entitlement Date - Unlisted RNV Shares
01/12/25	07:00:13	1 Dec 2025	Determination of Record Date and Entitlement	Determination of Record Date and Entitlement
25/11/25	07:00:20	25 Nov 2025	Holding(s) in Company	Holding(s) in Company
24/11/25	07:00:11	24 Nov 2025	Director/PDMR Shareholding	Director/PDMR Shareholding
18/11/25	07:00:09	18 Nov 2025	Executed License Agreement & Transaction Update	Executed License Agreement & Transaction Update
03/11/25	07:00:12	3 Nov 2025	MK Cell Out-License & Lyramid SPA Update	MK Cell Out-License & Lyramid SPA Update
16/10/25	07:00:02	16 Oct 2025	Fundraise & Transaction Update	Fundraise & Transaction Update
30/09/25	07:00:04	30 Sept 2025	Interim Results to 30 June 2025	Interim Results to 30 June 2025
24/09/25	07:00:15	24 Sept 2025	Investor Presentation via Engage Investor	Investor Presentation via Engage Investor
08/09/25	07:00:09	8 Sept 2025	Proposed Acquisition of Clinical Stage Company	Proposed Acquisition of Clinical Stage Company
28/08/25	07:00:02	28 Aug 2025	Lyramid SPA 2nd Extension & Carve Out	Lyramid SPA 2nd Extension & Carve Out
07/07/25	07:00:09	7 Jul 2025	Director/PDMR Shareholding	Director/PDMR Shareholding
30/06/25	07:00:14	30 Jun 2025	Director/PDMR Shareholding	Director/PDMR Shareholding
27/06/25	07:00:05	27 Jun 2025	Lyramid SPA Extension	Lyramid SPA Extension
26/06/25	13:00:01	26 Jun 2025	Results of AGM	Results of AGM
13/06/25	16:00:01	13 Jun 2025	Issue of Equity	Issue of Equity
02/06/25	07:00:14	2 Jun 2025	Notice of Annual General Meeting	Notice of Annual General Meeting
23/05/25	07:00:07	23 May 2025	Extension of Convertible Loan Notes	Extension of Convertible Loan Notes
13/05/25	07:00:04	13 May 2025	Corporate Update	Corporate Update
30/04/25	07:00:09	30 Apr 2025	Annual Report & Financial Statements - 31 Dec 2024	Annual Report & Financial Statements - 31 Dec 2024
14/03/25	07:00:07	14 Mar 2025	Private Placing and Conversion of CLNs	Private Placing and Conversion of CLNs